PTEN deletion in prostate cancer cells does not associate with loss of RAD51 function: Implications for radiotherapy and chemotherapy

Michael Fraser, Helen Zhao, Kaisa R. Luoto, Cecilia Lundin, Carla Coackley, Norman Chan, Anthony M. Joshua, Tarek A. Bismar, Andrew Evans, Thomas Helleday, Robert G. Bristow*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'PTEN deletion in prostate cancer cells does not associate with loss of RAD51 function: Implications for radiotherapy and chemotherapy'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Agricultural and Biological Sciences

Biochemistry, Genetics and Molecular Biology